Career history of George Yu
Former positions of George Yu
| Companies | Position | Start | End |
|---|---|---|---|
| MEDISUN PRECISION MEDICINE LTD. | Director/Board Member | 2012-08-28 | 2017-01-18 |
| Chief Executive Officer | 2012-08-28 | 2017-01-18 | |
| Director of Finance/CFO | 2012-08-28 | 2017-01-18 | |
| Founder | 2012-08-28 | 2017-01-18 | |
| President | 2012-08-28 | 2017-01-18 | |
SinoBiomed, Inc.
 SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Director/Board Member | 2011-02-03 | 2011-08-03 |
| Director of Finance/CFO | 2011-06-15 | 2011-08-03 | |
| President | 2010-09-02 | 2011-06-15 | |
| LOGIQ, INC. | Director/Board Member | 2012-02-29 | - |
| Director of Finance/CFO | 2012-02-29 | 2012-12-19 | |
| President | 2012-02-29 | 2012-12-19 |
Training of George Yu
| Eberhard Karls Universität Tübingen | Doctorate Degree |
| Columbia Business School | Masters Business Admin |
Statistics
International
| United States | 3 |
| China | 2 |
| Germany | 2 |
Operational
| Director/Board Member | 3 |
| Director of Finance/CFO | 3 |
| President | 3 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| LOGIQ, INC. | Technology Services |
| Private companies | 2 |
|---|---|
SinoBiomed, Inc.
SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Health Technology |
Medisun Precision Medicine Ltd.
 Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands. | Health Technology |
- Stock Market
- Insiders
- George Yu
- Experience
